Precision BioSciences, Inc.
NASDAQ:DTIL
4.75 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 48.727 | 25.098 | 115.529 | 24.285 | 22.238 | 10.883 | 6.484 | 7.015 |
| Cost of Revenue
| 8.255 | 9.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 40.472 | 16.094 | 115.529 | 24.285 | 22.238 | 10.883 | 6.484 | 7.015 |
| Gross Profit Ratio
| 0.831 | 0.641 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 53.375 | 83.939 | 115.238 | 98.061 | 82.416 | 45.122 | 20.324 | 9.102 |
| General & Administrative Expenses
| 39.088 | 41.525 | 39.693 | 36.052 | 27.026 | 13.673 | 8.016 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 39.088 | 41.525 | 39.693 | 36.052 | 27.026 | 13.673 | 8.016 | 6.101 |
| Other Expenses
| 0 | 0 | 0 | 0 | -9.758 | 0 | 0 | 0 |
| Operating Expenses
| 92.463 | 125.464 | 154.931 | 134.113 | 109.442 | 58.795 | 28.34 | 15.203 |
| Operating Income
| -43.736 | -100.366 | -39.402 | -109.828 | -87.204 | -47.912 | -21.974 | -8.828 |
| Operating Income Ratio
| -0.898 | -3.999 | -0.341 | -4.522 | -3.921 | -4.402 | -3.389 | -1.258 |
| Total Other Income Expenses Net
| 1.209 | 27.457 | 8.8 | 0.822 | -5.673 | 1.875 | 0.872 | 0.572 |
| Income Before Tax
| -42.527 | -111.637 | -30.602 | -109.006 | -92.877 | -46.037 | -21.102 | -8.256 |
| Income Before Tax Ratio
| -0.873 | -4.448 | -0.265 | -4.489 | -4.176 | -4.23 | -3.254 | -1.177 |
| Income Tax Expense
| 0 | 11.271 | 0.316 | 10.429 | -9.576 | 1.875 | -0.754 | -0.005 |
| Net Income
| -61.319 | -122.908 | -30.918 | -109.006 | -83.301 | -46.037 | -21.102 | -8.251 |
| Net Income Ratio
| -1.258 | -4.897 | -0.268 | -4.489 | -3.746 | -4.23 | -3.254 | -1.176 |
| EPS
| -15.96 | -41.95 | -15.8 | -62.85 | -59.5 | -28.17 | -18.81 | -0.005 |
| EPS Diluted
| -15.96 | -41.95 | -15.8 | -62.85 | -59.5 | -28.17 | -18.81 | -0.005 |
| EBITDA
| -32.042 | -62.794 | -20.273 | -99.193 | -87.378 | -43.683 | -20.421 | -8.188 |
| EBITDA Ratio
| -0.658 | -3.923 | -0.249 | -4.085 | -3.929 | -4.186 | -3.131 | -1.167 |